The adenoviral E1A oncoprotein activates the Smad7 promoter: Requirement of a functional E-box

International Journal of Oncology

Volumn 35, Issue 6, 2009, Pages 1493-1498

  Dole, Vandana S ^a,g   Smola, Hans ^a,h   Dooley, Steven ^b   Said, Harun M ^c   Oldak, Monika ^d,e   Pfister, Herbert J ^f   Smola, Sigrun ^a,d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^g Charles River   (United States)

^h Paul Hartmann AG   (Germany)

Author keywords

Adenovirus; E1A; Human papillomavirus; Oncoprotein; Smad; Transforming growth factor

Indexed keywords

E1A PROTEIN; ONCOPROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; SMAD7 PROTEIN, HUMAN;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; E BOX ELEMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; WART VIRUS; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PAPILLOMA VIRUS; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIRUS CELL TRANSFORMATION;

ADENOVIRUS E1A PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; E-BOX ELEMENTS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; PAPILLOMAVIRIDAE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 73949155484     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000468     Document Type: Article

References (40)

1. Feng XH and Derynck R: Specificity and versatility in TGFsignaling through Smads. Annu Rev Cell Dev Biol 21: 659-693, 2005.
2. Massague J: TGFbeta in cancer. Cell 134: 215-230, 2008.
3. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL and Falb D: The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89: 1165-1173, 1997.
4. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH and ten Dijke P: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389: 631-635, 1997.
5. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6: 1365-1375, 2000.
6. Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM and Dooley S: Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem 275: 29308-29317, 2000.
7. Von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D and Bottinger EP: Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem 275: 11320-11326, 2000.
8. Nagarajan RP, Zhang J, Li W and Chen Y: Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J Biol Chem 274: 33412-33418, 1999.
9. Ulloa L, Doody J and Massague J: Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/ STAT pathway. Nature 397: 710-713, 1999.
10. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M and Bottinger EP: A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev 14: 187-197, 2000.
11. Quan T, He T, Voorhees JJ and Fisher GJ: Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts. J Biol Chem 280: 8079-8085, 2005.
12. Dooley S, Said HM, Gressner AM, Floege J, En-Nia A and Mertens PR: Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 281: 1784-1795, 2006.
13. Brodin G, Ahgren A, ten Dijke P, Heldin CH and Heuchel R: Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J Biol Chem 275: 29023-29030, 2000.
14. Corre S and Galibert MD: Upstream stimulating factors: highly versatile stress-responsive transcription factors. Pigment Cell Res 18: 337-348, 2005.
15. Hua X, Miller ZA, Benchabane H, Wrana JL and Lodish HF: Synergism between transcription factors TFE3 and Smad3 in transforming growth factor-beta-induced transcription of the Smad7 gene. J Biol Chem 275: 33205-33208, 2000.
16. Tarakanova VL and Wold WS: Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells. J Virol 77: 9324-9336, 2003.
17. Datto MB, Hu PP, Kowalik TF, Yingling J and Wang XF: The viral oncoprotein E1A blocks transforming growth factor betamediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol Cell Biol 17: 2030-2037, 1997.
18. Shen X, Hu PP, Liberati NT, Datto MB, Frederick JP and Wang XF: TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell 9: 3309-3319, 1998.
19. Nishihara A, Hanai JI, Okamoto N, Yanagisawa J, Kato S, Miyazono K and Kawabata M: Role of p300, a transcriptional coactivator, in signalling of TGF-beta. Genes Cells 3: 613-623, 1998.
20. Nishihara A, Hanai J, Imamura T, Miyazono K and Kawabata M: E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. J Biol Chem 274: 28716-28723, 1999.
21. Lee DK, Kim BC, Kim IY, Cho EA, Satterwhite DJ and Kim SJ: The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence. J Biol Chem 277: 38557-38564, 2002.
22. Habig M, Smola H, Dole VS, Derynck R, Pfister H and Smola-Hess S: E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity. Arch Virol 151: 1961-1972, 2006.
23. Mendoza JA, Jacob Y, Cassonnet P and Favre M: Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3. J Virol 80: 12420-12424, 2006.
24. Pear WS, Nolan GP, Scott ML and Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392-8396, 1993.
25. Smola-Hess S, Pahne J, Mauch C, Zigrino P, Smola H and Pfister HJ: Expression of membrane type 1 matrix metalloproteinase in papillomavirus- positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J Gen Virol 86: 1291-1296, 2005.
26. Hadaschik D, Hinterkeuser K, Oldak M, Pfister HJ and Smola-Hess S: The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J Virol 77: 5253-5265, 2003.
27. Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, Hanyu A, Ebina M, Nukiwa T, Miyazawa K, Imamura T and Miyazono K: Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J 22: 6458-6470, 2003.
28. Sirito M, Lin Q, Maity T and Sawadogo M: Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res 22: 427-433, 1994.
29. Aperlo C, Boulukos KE and Pognonec P: The basic region/helixloop-helix/ leucine repeat transcription factor USF interferes with Ras transformation. Eur J Biochem 241: 249-253, 1996.
30. Qyang Y, Luo X, Lu T, Ismail PM, Krylov D, Vinson C and Sawadogo M: Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol 19: 1508-1517, 1999.
31. Kutz SM, Higgins CE, Samarakoon R, Higgins SP, Allen RR, Qi L and Higgins PJ: TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp Cell Res 312: 1093-1105, 2006.
32. Liu F and Green MR: Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature 368: 520-525, 1994.
33. Chang LS, Shi Y and Shenk T: Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J Virol 63: 3479-3488, 1989.
34. Galibert MD, Carreira S and Goding CR: The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. EMBO J 20: 5022-5031, 2001.
35. Xiao Q, Kenessey A and Ojamaa K: Role of USF1 phosphorylation on cardiac alpha-myosin heavy chain promoter activity. Am J Physiol Heart Circ Physiol 283: H213-H219, 2002.
36. Cheung E, Mayr P, Coda-Zabetta F, Woodman PG and Boam DS: DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation. Biochem J 344 1: 145-152, 1999.
37. Nowak M, Helleboid-Chapman A, Jakel H, Martin G, Duran-Sandoval D, Staels B, Rubin EM, Pennacchio LA, Taskinen MR, Fruchart-Najib J and Fruchart JC: Insulin-mediated downregulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor. Mol Cell Biol 25: 1537-1548, 2005.
38. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM and Moses HL: TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785, 1990.
39. Zimmermann H, Degenkolbe R, Bernard HU and O'Connor MJ: The human papillomavirus type 16 E6 oncoprotein can downregulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol 73: 6209-6219, 1999.
40. Phelps WC, Yee CL, Münger K and Howley PM: The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53: 539-547, 1988.